HomeNEO • BMV
add
NeoGenomics, Inc.
Nakaraang pagsara
$200.00
Sakop ng taon
$200.00 - $340.00
Market cap
965.21M USD
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 168.04M | 7.55% |
Gastos sa pagpapatakbo | 101.07M | 7.94% |
Net na kita | -25.92M | 4.21% |
Net profit margin | -15.43 | 10.91% |
Kita sa bawat share | 0.00 | 100.00% |
EBITDA | -10.10M | -1.97% |
Aktuwal na % ng binabayarang buwis | -1.04% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 358.08M | -6.95% |
Kabuuang asset | 1.60B | -2.37% |
Kabuuang sagutin | 713.16M | -0.53% |
Kabuuang equity | 888.27M | — |
Natitirang share | 128.69M | — |
Presyo para makapag-book | 28.90 | — |
Return on assets | -4.29% | — |
Return on capital | -4.64% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -25.92M | 4.21% |
Cash mula sa mga operasyon | -25.33M | 2.27% |
Cash mula sa pag-invest | 3.56M | -75.49% |
Cash mula sa financing | 949.00K | 16.30% |
Net change in cash | -20.82M | -96.88% |
Malayang cash flow | -21.96M | 6.19% |
Tungkol
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is a high-complexity CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
Itinatag
2002
Headquarters
Website
Mga Empleyado
2,200
